Bidirectional Crosstalk Between Macrophage Efferocytosis and Polarization in Asthma: Endotype-Specific Mechanisms and Therapeutic Perspectives
Abstract
Abstract Despite advances in asthma treatment, some patients continue to experience persistent airway inflammation, poor treatment response, and progressive airway remodeling. One possible contributor is impaired efferocytosis, the regulated recognition and clearance of apoptotic cells by macrophages, which can hinder inflammation resolution. This review synthesizes literature available through August 2026 on the reciprocal relationship between macrophage efferocytosis and polarization across asthma endotypes. Defective efferocytosis allows apoptotic cells to accumulate and may shift macrophages toward pathological functional states. Conversely, these altered macrophage states can further compromise efferocytic capacity, creating self-reinforcing feedback loops. In type 2-high (T2-high) asthma, this interplay may promote pro-fibrotic M2-like macrophage responses and airway remodeling. In type 2-low (T2-low) asthma, particularly neutrophilic and some obesity-associated phenotypes, impaired clearance is linked to persistent M1-like inflammation, oxidative stress, and neutrophil extracellular traps, potentially contributing to corticosteroid resistance. Strategies that enhance efferocytosis, promote inflammation resolution, or modulate macrophage metabolism may complement existing treatments. However, most proposed interventions remain preclinical or at an early translational stage, and endotype-specific clinical studies are needed to establish their efficacy and safety for difficult-to-treat asthma across distinct endotypes.